Phase 4 Leukemia Clinical Trials
14 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–14 of 14 trials
Recruiting
Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Acute Lymphoblastic LeukemiaMixed Phenotype Acute LeukemiaLymphoblastic Lymphoma
St. Jude Children's Research Hospital850 enrolled3 locationsNCT06289673
Recruiting
Phase 4
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
Acute Myeloid LeukemiaChemotherapy EffectNewly Diagnosed
Fujian Medical University Union Hospital100 enrolled1 locationNCT07561892
Recruiting
Phase 4
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic
Eli Lilly and Company150 enrolled53 locationsNCT07218341
Recruiting
Phase 4
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
CholangiocarcinomaSolid Tumor MalignanciesGlioma+1 more
Rigel Pharmaceuticals16 enrolled2 locationsNCT07486713
Recruiting
Phase 4
Asciminib Roll-over Study
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals347 enrolled84 locationsNCT04877522
Recruiting
Phase 4
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company279 enrolled36 locationsNCT06876662
Recruiting
Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company787 enrolled38 locationsNCT06876649
Recruiting
Phase 4
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Acute Myeloid Leukemia
Virginia Commonwealth University12 enrolled1 locationNCT06370000
Recruiting
Phase 4
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
Acute Myeloid Leukemia
AbbVie100 enrolled11 locationsNCT07044687
Recruiting
Phase 4
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaNeutropenic Fever
Gadjah Mada University120 enrolled1 locationNCT07016165
Recruiting
Phase 4
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaLeukaemia (Acute)
Ain Shams University42 enrolled2 locationsNCT06918054
Recruiting
Phase 4
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
Acute Myeloid Leukemia
He Huang118 enrolled1 locationNCT06571825
Recruiting
Phase 4
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Acute B-cell Lymphoblastic Leukemia
Suping ZHANG60 enrolled1 locationNCT06339775
Recruiting
Phase 4
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Acute Lymphoblastic Leukemia
Swiss Pediatric Oncology Group1,000 enrolled4 locationsNCT02670564